Home / Auditor changes / Obsidian Therapeutics, Inc.
Filed 2026-08-03 路 Form 8-K 路 Accession 0001193125-26-330810 nano
Price before filing: $15.62 (2026-07-31 close, split/dividend-adjusted)
Market cap at flag: $19.8M (2026-08-03) 路 Latest: $12.2M (2026-10-16)
| Window | OBX | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +8.8% | +2.4% | +6.4% | 2026-09-02 |
| 90 days | pending | pending | until 2026-11-01 | |
| 180 days | pending | pending | until 2027-01-30 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"Resignation of Directors In accordance with the Merger Agreement, immediately prior to the Mergers, J. Mel Sorensen, M.D. and Julie Feder resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with our company relating to our operations, policies or practices."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: routine (post-merger auditor consolidation)
Disagreements reported: yes
New auditor: KPMG LLP
Why this score: routine: auditor replaced after company merger/SPAC deal
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.